A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

Clinical trial NCT00885196 · COMPLETED

Trial details

NCT number: NCT00885196
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate and Severe Plaque Psoriasis

Start date: 2009-04-01
Primary completion: 2011-08-01
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.